Choline acetyltransferase

Otonomo to Participate in Citi’s 2021 Car of The Future Virtual Symposium and the 3rd Annual Mizuho Auto Technology Seminar

Retrieved on: 
Thursday, May 6, 2021

Ben will participate in a fireside chat at 9:30 a.m.

Key Points: 
  • Ben will participate in a fireside chat at 9:30 a.m.
  • ET and will be available for 1 on 1 meetings throughout the day.\nThis conference will take place May 18th to May 27th.
  • Ben is scheduled to participate in a fireside chat on May 24th at 9:30 a.m.
  • Otonomo is headquartered and has an R&D center in Israel, and it has a presence in the United States, and Europe.\n'

Cerevel Therapeutics to Present at the Stifel 3rd Annual CNS Day Event

Retrieved on: 
Monday, March 22, 2021

will participate in a fireside chat at the Stifel 3rd Annual CNS Day on Wednesday, March 31, 2021 at 9:00 a.m. EDT.

Key Points: 
  • will participate in a fireside chat at the Stifel 3rd Annual CNS Day on Wednesday, March 31, 2021 at 9:00 a.m. EDT.
  • The live webcast of the fireside chat can be accessed on the investor relations section of the Cerevel Therapeutics website here .
  • Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases.
  • Forward-looking statements in this press release include, but are not limited to, statements about our participation at the Stifel 3rd Annual CNS Day Event and the potential attributes and benefits of our product candidates.

Relmada Therapeutics Announces Participation in the 2021 SVB Leerink Global Healthcare Conference

Retrieved on: 
Tuesday, February 23, 2021

NEW YORK, Feb. 23, 2021 /PRNewswire/ -- RelmadaTherapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),today announced that Sergio Traversa, Chief Executive Officer of Relmada, will participate in a fireside chat at the 2021 SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 3:40 p.m. Eastern Time.

Key Points: 
  • NEW YORK, Feb. 23, 2021 /PRNewswire/ -- RelmadaTherapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),today announced that Sergio Traversa, Chief Executive Officer of Relmada, will participate in a fireside chat at the 2021 SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 3:40 p.m. Eastern Time.
  • A live webcast of the fireside chat will be available by visiting the investors section of the Company's website at www.relmada.com .
  • Relmada' s lead program, REL-1017, is a novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission.
  • Relmada undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Relmada Therapeutics to Participate in Upcoming Investor Conferences

Retrieved on: 
Tuesday, November 17, 2020

NEW YORK, Nov. 17, 2020 /PRNewswire/ --RelmadaTherapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Sergio Traversa, Chief Executive Officer of Relmada, will participate in the following upcoming virtual investor conferences:

Key Points: 
  • NEW YORK, Nov. 17, 2020 /PRNewswire/ --RelmadaTherapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Sergio Traversa, Chief Executive Officer of Relmada, will participate in the following upcoming virtual investor conferences:
    Webcast: A live webcast of the fireside chat will be available by visiting the "Investors" section of the company's website: www.relmada.com .
  • A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.
  • Management will participate in a fireside chat, which will be accessible beginning on November 23, 2020, via the "Investors" section of the company's website: www.relmada.com .The link will remain active for 90 days thereafter.
  • RelmadaTherapeutics is a late-stage pharmaceutical company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD).

Yardi Introduces RENTCafé Chat IQ

Retrieved on: 
Wednesday, August 12, 2020

SANTA BARBARA, Calif., Aug. 12, 2020 /PRNewswire/ -- Apartment management companies can now respond instantly to customer inquiries with RENTCaf Chat IQ .

Key Points: 
  • SANTA BARBARA, Calif., Aug. 12, 2020 /PRNewswire/ -- Apartment management companies can now respond instantly to customer inquiries with RENTCaf Chat IQ .
  • Chat IQ improves the customer experience for renters by providing immediate, intelligent and accurate responses to chat and text messages even when a business is closed.
  • "RENTCaf Chat IQ uses natural language processing and machine learning to converse with potential renters.
  • "RENTCaf Chat IQ ensures properties never miss an incoming leasing opportunity via chat or text, day or night, and it frees up onsite staff to focus on high-value interactions with applicants and residents."